Cargando…
Activity and side effects of imatinib in patients with gastrointestinal stromal tumors: data from a german multicenter trial
Gastrointestinal stromal tumors (GIST) are mesenchymal tumors that in the past were classified as leiomyosarcomas or leiomyomas not responding to standard sarcoma chemotherapy. In several phase I and II trials the efficacy and safety of imatinib was shown before the largest trial ever performed in a...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352192/ https://www.ncbi.nlm.nih.gov/pubmed/21719393 http://dx.doi.org/10.1186/2047-783X-16-5-206 |